Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Civitas Solutions, Inc. (CIVI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/20/2019 GN Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm
03/18/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
03/11/2019 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in Civitas Solutions, Inc.
03/08/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2019 8-K Quarterly results
03/08/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/06/2019 GN Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions — Research Highlights Growth, Revenue, and Consolidated Results
02/28/2019 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/28/2019 8-K Quarterly results
02/22/2019 GN CIVITAS SOLUTIONS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
02/14/2019 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
02/13/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2019 GN Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Fidelity Southern, Civitas, and MedEquities on Behalf of Stockholders and Encourages Investors to Contact the Firm
02/04/2019 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/04/2019 10-Q Quarterly Report for the period ended December 31, 2018
02/04/2019 8-K Quarterly results
01/23/2019 8-K Results of Operations and Financial Condition, Regulation FD Disclosure
01/22/2019 10-K/A Annual Report for the period ended September 30, 2018 [amend]
01/22/2019 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
01/10/2019 SC 13G/A FMR LLC reports a 1.2% stake in CIVITAS SOLUTIONS INC
01/02/2019 GN Report: Exploring Fundamental Drivers Behind Energy Transfer LP, Cable One, DTE Energy, Civitas Solutions, Owens Realty Mortgage, and Fortress Biotech — New Horizons, Emerging Trends, and Upcoming Developments
12/28/2018 SC 13D Centerbridge Capital Partners III, L.P. reports a 54% stake in Civitas Solutions, Inc.
12/19/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 18, 2018 CIVITAS SOLUTIONS, INC. Delaware 001-36623 65-1309110 313 Congress Street, 6th Floor Boston, Massachusetts 02210 790-4800 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 unde...",
"Agreement and Plan of Merger, by and among Civitas Solutions Inc., Celtic Intermediate Corp., and Celtic Tier II Corp",
"Voting Agreement, by and among Celtic Intermediate Corp. and certain stockholders of Civitas Solutions, Inc"
12/19/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/19/2018 GN Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Civitas Solutions, Inc. (CIVI) on Behalf of Stockholders and Encourages CIVI Investors to Contact the Firm
12/18/2018 GN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Civitas Solutions, Inc. to Centerbridge Partners, L.P. is Fair to Shareholders
12/13/2018 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/13/2018 10-K Annual Report for the period ended September 30, 2018
12/13/2018 8-K Quarterly results
Docs: "Civitas Solutions Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results"
08/31/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 28, 2018 CIVITAS SOLUTIONS, INC. Delaware 001-36623 65-1309110 313 Congress Street, 6th Floor Boston, Massachusetts 02210 790-4800 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under...",
"Civitas Solutions, Inc. Announces Appointment of Robert Rosner to its Board of Directors Boston, MA, August 30, 2018 - Civitas Solutions, Inc. today announced that, effective as of August 28, 2018, the Board has approved an increase in its size from eight to nine members and appointed Robert L. Rosner as a Director. Mr. Rosner is an “independent director” as defined by the rules of the New York Stock Exchange. Mr. Rosner will not serve on any committees at this time. Bruce Nardella, Chief Executive Officer and Chair of the Board, stated, “Robert Rosner has been advising and supporting management teams across a wide variety of industries, including healthcare, for more than 30 years, and we are delighted to welcome him to Civitas. We are confident that his impressive breadth of experience a..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy